Stevens Capital Management LP Invests $2.48 Million in Pacific Biosciences of California (PACB …

Millennium Management LLC boosted its holdings in shares of Pacific Biosciences of California by 18.9% during the 2nd quarter. Millennium …

Pacific Biosciences of California logoStevens Capital Management LP purchased a new stake in shares of Pacific Biosciences of California (NASDAQ:PACB) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 334,603 shares of the biotechnology company’s stock, valued at approximately $2,476,000. Stevens Capital Management LP owned approximately 0.22% of Pacific Biosciences of California at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in PACB. BlackRock Inc. boosted its holdings in shares of Pacific Biosciences of California by 9.7% during the 2nd quarter. BlackRock Inc. now owns 9,642,174 shares of the biotechnology company’s stock worth $34,230,000 after buying an additional 849,435 shares during the period. Millennium Management LLC boosted its holdings in shares of Pacific Biosciences of California by 18.9% during the 2nd quarter. Millennium Management LLC now owns 344,194 shares of the biotechnology company’s stock worth $1,222,000 after buying an additional 54,671 shares during the period. Northern Trust Corp boosted its holdings in shares of Pacific Biosciences of California by 10.6% during the 2nd quarter. Northern Trust Corp now owns 1,463,230 shares of the biotechnology company’s stock worth $5,195,000 after buying an additional 140,090 shares during the period. Moloney Securities Asset Management LLC boosted its holdings in shares of Pacific Biosciences of California by 9.2% during the 3rd quarter. Moloney Securities Asset Management LLC now owns 467,961 shares of the biotechnology company’s stock worth $2,532,000 after buying an additional 39,500 shares during the period. Finally, Victory Capital Management Inc. bought a new stake in shares of Pacific Biosciences of California during the 3rd quarter worth about $1,623,000. Institutional investors own 70.99% of the company’s stock.

Several analysts recently commented on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and set a $8.00 target price on shares of Pacific Biosciences of California in a report on Sunday, October 21st. BidaskClub upgraded shares of Pacific Biosciences of California from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 11th. Cowen initiated coverage on shares of Pacific Biosciences of California in a research note on Friday, October 19th. They issued an “outperform” rating and a $6.50 price objective for the company. Finally, ValuEngine upgraded shares of Pacific Biosciences of California from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 2nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $5.64.

Shares of Pacific Biosciences of California stock opened at $7.13 on Friday. Pacific Biosciences of California has a twelve month low of $2.02 and a twelve month high of $7.84. The company has a quick ratio of 5.74, a current ratio of 6.65 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $1.07 billion, a price-to-earnings ratio of -9.38 and a beta of 2.30.

Pacific Biosciences of California (NASDAQ:PACB) last issued its quarterly earnings data on Monday, February 11th. The biotechnology company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.13) by ($0.08). Pacific Biosciences of California had a negative return on equity of 96.13% and a negative net margin of 130.44%. The business had revenue of $19.53 million during the quarter, compared to analyst estimates of $21.08 million. As a group, equities research analysts expect that Pacific Biosciences of California will post -0.56 EPS for the current fiscal year.

In other Pacific Biosciences of California news, insider Kathy Ordonez sold 25,000 shares of Pacific Biosciences of California stock in a transaction dated Tuesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $188,500.00. Following the completion of the sale, the insider now owns 68,750 shares in the company, valued at approximately $518,375. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 13.40% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Stevens Capital Management LP Invests $2.48 Million in Pacific Biosciences of California (PACB) Stock” was originally posted by Fairfield Current and is the sole property of of Fairfield Current. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.fairfieldcurrent.com/news/2019/02/16/stevens-capital-management-lp-invests-2-48-million-in-pacific-biosciences-of-california-pacb-stock.html.

Pacific Biosciences of California Profile

Pacific Biosciences of California, Inc designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time.

Featured Article: What is systematic risk?

Want to see what other hedge funds are holding PACB?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pacific Biosciences of California (NASDAQ:PACB).

Institutional Ownership by Quarter for Pacific Biosciences of California (NASDAQ:PACB)

Receive News & Ratings for Pacific Biosciences of California Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Pacific Biosciences of California and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Top Technical Indicators for Laredo Petroleum, Inc. (LPI)

Taking everything into account, Laredo Petroleum, Inc. (NYSE:LPI) scores 32% Sell on the technical side. The stock is also flashing a Sell from the …

Taking everything into account, Laredo Petroleum, Inc. (NYSE:LPI) scores 32% Sell on the technical side. The stock is also flashing a Sell from the Barchart TrendSpotter trading system. Traders hoping to speculate on the LPI’s short-term trajectory should know that short terms indicators for the stock averaged 0% Hold with an average daily trading volume over the past 20 days at 4546845 shares. LPI stock has overall a 0.25% Sell signal considering medium term indicators and the 50-day average daily volume remained almost 4664994 shares. It’s also worth noting that the stock, whose average daily volume over the 100 days prior to this writing was shares, is 67% Sell on the basis of long term indicators.

The share price is currently staying around the first support level of $3.62. Below this, the next support is placed in the zone of $3.39. Till the time, the LPI stock trades above this level, bulls have nothing to fear. On momentum oscillators front, ‘RSI’ has touched 52.12 on daily chart, which may remain a cause for concern. If the price breaks below $3.39 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $3.99 mark may result into a pull-back move towards $4.13 level.

Laredo Petroleum, Inc. (LPI) is projected to climb by 43.12 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $14 price as 12-month high target. This represents a whopping 263.64 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $5, which represents a return potential of 29.87 percent when compared to the closing price of the stock of $3.85 on Thursday, February 14. The lowest price target for the stock is $1.5 — slightly more than -61.04 percent from LPI’s current share price.

Here’s a rundown of insider trading activity for sense of Laredo Petroleum, Inc. (NYSE:LPI). The earliest insider trade took place on 09/27/2018. Warburg Pincus Private Equity parted with a total of 12.3 million shares of company at average share price of $8.08. The total for the sales was set at $99.38 million. After this transaction, the 10% Owner account balance stood at 91.33 million shares. The stock lost -52.35 percent since that insider sale. On 09/27/2018, Kagan Peter, Director, sold 12.3 million shares at a price per share of $8.08. This removed 99.38 million shares from the insider’s fortune and the stock saw a -52.35 percent retreat in value since the news became public. This transaction left 51.29 million shares in the Director account. On 09/27/2018, Director Levy James R. performed a sale transaction worth $99.38 million. This sale at $8.08 each has eliminated 12.3 million shares from the insider’s portfolio position. Meanwhile, shares have recorded -52.35 percent decrease since the transaction was reported. The insider now is left with 51.31 million shares remaining in the account. Warburg Pincus Private Equity, who performs the 10% Owner job, sold 14.2 million shares for $105.36 million. The disposal occurred on 09/11/2018 was priced at $7.42 per share. The share price plunged -48.11 percent since the reporting date. Warburg Pincus Private Equity now left with a stake of 104 million LPI stock worth $400.4 million after the insider selling.

LPI shares accumulated 0.06 points or 1.58 percent on Thursday to $3.85 with a heavy trade volume of 12.058 million shares. After opening the session at $3.53, the shares went as high as $3.9 and as low as $3.53, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $906 million and now has 235.23 million shares outstanding. Laredo Petroleum, Inc. (LPI) stock has lost -3.75 percent of market value in 21 trading days.

Analysts at Piper Jaffray cut their rating on shares of Laredo Petroleum, Inc. (NYSE:LPI) from Overweight to Neutral in their opinion released on January 09. CapitalOne analysts have downgraded their rating of LPI stock from Overweight to Underweight in a separate flash note to investors on December 20. Analysts at Credit Suisse downgraded the stock to a Underperform call from its previous Neutral stance, in a research note that dated back to December 19.

LPI stock has a trailing 3-year beta of 1.55, offering the possibility of a higher rate of return, but also posing more risk. The portion of a company’s profit allocated to each outstanding share of common stock was $2.45 a share in the trailing twelve months. The stock’s value has surged 6.35 percent year to date (YTD) against a decline of -49.14 percent in 12 month’s time. The company’s shares still trade -65.55 percent away from its 1-year high of $11.18 and 28.33 percent up from 52-week low of $3.00. The average consensus rating on the company is 2.9, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a sell.

Shares of Laredo Petroleum, Inc. (LPI) are trading at a P/E ratio of 1.55 times earnings reported for the past 12 months. The industry LPI operates in has an average P/E of 9.44. Its P/E ratio went as low as 4.64X and as high as 31.92 over the 5-year span. Further, it is sporting a 0.8 on the Price-to-Sales ratio. Compare this with the industry average P/S of 77.29. 60 percent is the gross profit margin for Laredo Petroleum, Inc. and operating margin sits at 31.3 percent. Along with this, the net profit margin is 51.6 percent.

Analysts are forecasting revenue to suffer decline of -2.1 percent to $235M in the next fiscal quarter, while earnings are seen soaring by nearly 31.58 percent to $0.25 per share. History has shown that shares in Laredo Petroleum, Inc. have gone down on 16 different earnings reaction days and are predicted to add 0.06 percent when the company reports upcoming earnings. In last reported earnings results, it earned $0.27 per share, worse than the $0.29, adjusted, expected by Thomson Reuters consensus estimate. Revenue was $215M, worse than the $234M analysts expected. Earnings are estimated to increase by 297.7 percent this year, -43.3 percent next year and continue to increase by 10.49 percent annually for the next 5 years.

Related Posts:

  • No Related Posts

WINTON GROUP Ltd Buys 35571 Shares of Chemed Co. (CHE)

WINTON GROUP Ltd lifted its stake in Chemed Co. (NYSE:CHE) by 521.0% in the fourth quarter, according to the company in its most recent filing with …

Chemed logoWINTON GROUP Ltd lifted its stake in Chemed Co. (NYSE:CHE) by 521.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,399 shares of the company’s stock after buying an additional 35,571 shares during the period. WINTON GROUP Ltd owned about 0.26% of Chemed worth $12,011,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. TIAA CREF Investment Management LLC raised its holdings in shares of Chemed by 17.8% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 132,303 shares of the company’s stock worth $42,281,000 after buying an additional 19,963 shares in the last quarter. Ontario Teachers Pension Plan Board acquired a new position in shares of Chemed in the 3rd quarter worth approximately $351,000. First Hawaiian Bank raised its holdings in shares of Chemed by 21.3% in the 4th quarter. First Hawaiian Bank now owns 290 shares of the company’s stock worth $82,000 after buying an additional 51 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Chemed by 4.6% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 26,661 shares of the company’s stock worth $8,520,000 after buying an additional 1,169 shares in the last quarter. Finally, Fisher Asset Management LLC raised its holdings in shares of Chemed by 0.4% in the 4th quarter. Fisher Asset Management LLC now owns 477,261 shares of the company’s stock worth $135,198,000 after buying an additional 1,961 shares in the last quarter. 99.17% of the stock is owned by institutional investors and hedge funds.

Separately, Zacks Investment Research reissued a “buy” rating and issued a $342.00 target price on shares of Chemed in a report on Monday, November 12th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $324.00.

CHE stock traded up $0.64 during midday trading on Friday, reaching $312.50. 1,055 shares of the company’s stock traded hands, compared to its average volume of 117,736. Chemed Co. has a 1-year low of $243.95 and a 1-year high of $335.99. The stock has a market capitalization of $4.99 billion, a price-to-earnings ratio of 58.40, a P/E/G ratio of 1.75 and a beta of 1.20. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.14 and a quick ratio of 1.11.

In related news, insider Spencer S. Lee sold 669 shares of the firm’s stock in a transaction on Friday, November 30th. The stock was sold at an average price of $314.76, for a total transaction of $210,574.44. Following the completion of the sale, the insider now directly owns 30,589 shares of the company’s stock, valued at approximately $9,628,193.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicholas Michael Westfall sold 5,709 shares of the firm’s stock in a transaction on Tuesday, December 11th. The shares were sold at an average price of $301.75, for a total value of $1,722,690.75. Following the sale, the insider now directly owns 16,052 shares of the company’s stock, valued at $4,843,691. The disclosure for this sale can be found here. Insiders have sold a total of 16,378 shares of company stock valued at $4,956,265 over the last ninety days. Insiders own 4.82% of the company’s stock.

WARNING: This piece was posted by PressOracle and is the property of of PressOracle. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://pressoracle.com/news/2019/02/15/winton-group-ltd-buys-35571-shares-of-chemed-co-che.html.

Chemed Profile

Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

See Also: Differences Between Momentum Investing and Long Term Investing

Want to see what other hedge funds are holding CHE?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Chemed and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

WINTON GROUP Ltd Invests $11.83 Million in Evertec Inc (EVTC) Stock

WINTON GROUP Ltd acquired a new stake in Evertec Inc (NYSE:EVTC) in the fourth quarter, according to its most recent 13F filing with the Securities …

Evertec logoWINTON GROUP Ltd acquired a new stake in Evertec Inc (NYSE:EVTC) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 412,041 shares of the business services provider’s stock, valued at approximately $11,826,000. WINTON GROUP Ltd owned 0.57% of Evertec as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Massey Quick Simon & CO. LLC grew its holdings in Evertec by 20.0% during the 4th quarter. Massey Quick Simon & CO. LLC now owns 3,226 shares of the business services provider’s stock worth $93,000 after acquiring an additional 537 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Evertec by 19.0% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,169 shares of the business services provider’s stock worth $120,000 after acquiring an additional 665 shares during the period. Nkcfo LLC acquired a new stake in Evertec during the 4th quarter worth about $29,000. Victory Capital Management Inc. grew its holdings in Evertec by 4.1% during the 4th quarter. Victory Capital Management Inc. now owns 26,505 shares of the business services provider’s stock worth $761,000 after acquiring an additional 1,033 shares during the period. Finally, Quantamental Technologies LLC acquired a new stake in Evertec during the 4th quarter worth about $46,000. Institutional investors and hedge funds own 80.93% of the company’s stock.

In other news, insider Carlos J. Ramirez sold 44,378 shares of the stock in a transaction dated Thursday, December 6th. The shares were sold at an average price of $26.34, for a total transaction of $1,168,916.52. Following the transaction, the insider now owns 67,409 shares of the company’s stock, valued at approximately $1,775,553.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Tere Loubriel sold 2,900 shares of the stock in a transaction dated Thursday, December 20th. The stock was sold at an average price of $27.04, for a total transaction of $78,416.00. Following the transaction, the director now directly owns 18,879 shares in the company, valued at approximately $510,488.16. The disclosure for this sale can be found here. Insiders have sold a total of 87,278 shares of company stock worth $2,340,533 in the last three months. Insiders own 0.76% of the company’s stock.

EVTC has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded Evertec from a “hold” rating to a “buy” rating and set a $30.00 price target for the company in a report on Friday, November 2nd. Keefe, Bruyette & Woods initiated coverage on Evertec in a report on Thursday, December 6th. They set an “outperform” rating and a $32.00 price target for the company. Finally, Raymond James increased their price target on Evertec from $28.00 to $33.00 and gave the stock an “outperform” rating in a report on Monday, November 12th. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $26.14.

Shares of EVTC stock traded up $0.13 on Friday, reaching $28.79. 1,322 shares of the company were exchanged, compared to its average volume of 487,955. The stock has a market capitalization of $2.10 billion, a PE ratio of 19.63 and a beta of 0.65. The company has a debt-to-equity ratio of 2.52, a current ratio of 1.73 and a quick ratio of 1.73. Evertec Inc has a one year low of $15.45 and a one year high of $30.20.

TRADEMARK VIOLATION NOTICE: This report was first reported by PressOracle and is owned by of PressOracle. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://pressoracle.com/news/2019/02/15/winton-group-ltd-invests-11-83-million-in-evertec-inc-evtc-stock.html.

About Evertec

EVERTEC, Inc and its subsidiaries engage in transaction processing business serving financial institutions, merchants, corporations, and government agencies in Latin America and the Caribbean. The company operates through four segments: Payment Services – Puerto Rico & Caribbean, Payment Services – Latin America, Merchant Acquiring, and Business Solutions.

Recommended Story: Stock Symbols, CUSIP and Other Stock Identifiers

Want to see what other hedge funds are holding EVTC?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evertec Inc (NYSE:EVTC).

Institutional Ownership by Quarter for Evertec (NYSE:EVTC)

Receive News & Ratings for Evertec Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Evertec and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Vanguard Group Inc. Acquires 642938 Shares of Skyline Co. (SKY)

Vanguard Group Inc. raised its holdings in Skyline Co. (NYSEAMERICAN:SKY) by 196.0% during the third quarter, according to its most recent …

Skyline logoVanguard Group Inc. raised its holdings in Skyline Co. (NYSEAMERICAN:SKY) by 196.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 970,946 shares of the construction company’s stock after buying an additional 642,938 shares during the period. Vanguard Group Inc. owned about 1.71% of Skyline worth $27,740,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in SKY. Wells Fargo & Company MN lifted its stake in shares of Skyline by 1,097.1% in the third quarter. Wells Fargo & Company MN now owns 1,578,346 shares of the construction company’s stock valued at $45,093,000 after buying an additional 1,446,494 shares in the last quarter. BlackRock Inc. lifted its stake in shares of Skyline by 200.8% in the third quarter. BlackRock Inc. now owns 1,562,896 shares of the construction company’s stock valued at $44,651,000 after buying an additional 1,043,297 shares in the last quarter. FMR LLC lifted its stake in shares of Skyline by 656.9% in the third quarter. FMR LLC now owns 1,052,297 shares of the construction company’s stock valued at $30,064,000 after buying an additional 913,272 shares in the last quarter. Tygh Capital Management Inc. bought a new position in shares of Skyline in the third quarter valued at $13,552,000. Finally, GW&K Investment Management LLC bought a new position in shares of Skyline in the third quarter valued at $11,755,000.

In related news, insider Centerbridge Capital Partners sold 262,500 shares of the firm’s stock in a transaction dated Wednesday, December 5th. The shares were sold at an average price of $21.80, for a total transaction of $5,722,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Bain Capital Credit Member, Ll sold 1,750,000 shares of the firm’s stock in a transaction dated Friday, November 30th. The stock was sold at an average price of $21.80, for a total transaction of $38,150,000.00. The disclosure for this sale can be found here. Insiders have sold 3,012,500 shares of company stock valued at $65,672,500 in the last 90 days.

SKY opened at $19.30 on Friday. Skyline Co. has a fifty-two week low of $12.72 and a fifty-two week high of $35.65.

A number of research analysts recently weighed in on SKY shares. Royal Bank of Canada set a $34.00 price target on shares of Skyline and gave the company a “buy” rating in a research report on Wednesday, November 7th. Zacks Investment Research lowered shares of Skyline from a “hold” rating to a “sell” rating in a research report on Thursday, November 15th. Credit Suisse Group started coverage on shares of Skyline in a research report on Thursday, November 29th. They set a “neutral” rating and a $25.00 price target on the stock. Finally, Barclays set a $23.00 price target on shares of Skyline and gave the company a “buy” rating in a research report on Wednesday, December 12th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $27.43.

COPYRIGHT VIOLATION NOTICE: “Vanguard Group Inc. Acquires 642,938 Shares of Skyline Co. (SKY)” was first published by Fairfield Current and is owned by of Fairfield Current. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.fairfieldcurrent.com/news/2019/02/15/vanguard-group-inc-acquires-642938-shares-of-skyline-co-sky.html.

About Skyline

Skyline Corporation designs, produces, and markets manufactured housing, modular housing, and park models to independent dealers and manufactured housing communities in the United States and Canada. The company’s manufactured housing models include two to four bedrooms, kitchen, dining area, living room, one or two bathrooms, kitchen appliances, and central heating and cooling products, as well as exterior dormers and windows, interior or exterior accent columns, fireplaces, and whirlpool tubs.

Read More: Capital Gains

Want to see what other hedge funds are holding SKY?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Skyline Co. (NYSEAMERICAN:SKY).

Institutional Ownership by Quarter for Skyline (NYSEAMERICAN:SKY)

Receive News & Ratings for Skyline Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Skyline and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts